HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Fujitaka Selected Research

Nivolumab

2/2021A case with life-threatening secondary sclerosing cholangitis caused by nivolumab.
1/2018Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Fujitaka Research Topics

Disease

33Neoplasms (Cancer)
01/2024 - 03/2011
32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 06/2004
26Lung Neoplasms (Lung Cancer)
01/2024 - 03/2011
19Interstitial Lung Diseases (Interstitial Lung Disease)
11/2023 - 12/2005
12Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2024 - 01/2009
10Fibrosis (Cirrhosis)
01/2024 - 01/2017
9Idiopathic Pulmonary Fibrosis
05/2024 - 04/2010
9Lung Injury
05/2024 - 04/2009
8Asthma (Bronchial Asthma)
10/2023 - 01/2009
8Adenocarcinoma of Lung
01/2022 - 06/2011
6Neoplasm Metastasis (Metastasis)
09/2020 - 03/2011
5Adenocarcinoma
01/2023 - 03/2011
5Disease Progression
07/2022 - 12/2018
5Bronchiectasis
02/2021 - 01/2018
4Pneumonia (Pneumonitis)
10/2022 - 07/2011
4Venous Thromboembolism
01/2022 - 03/2019
3Acute Lung Injury
05/2024 - 01/2020
3Radiation Pneumonitis
11/2022 - 10/2021
3Hemorrhage
01/2022 - 08/2018
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021 - 10/2017
3Emphysema
04/2021 - 01/2016
3Inflammation (Inflammations)
01/2021 - 11/2017
3Lewis Lung Carcinoma
09/2018 - 11/2013
2Carcinogenesis
11/2022 - 10/2020
2Respiratory Insufficiency (Respiratory Failure)
02/2022 - 01/2017
2Dyspnea (Shortness of Breath)
02/2021 - 12/2005
2Sarcoidosis (Schaumann Disease)
01/2021 - 05/2012
2Carcinoma (Carcinomatosis)
01/2021 - 06/2011
2Intracranial Embolism
01/2020 - 03/2019
2Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2015
2Malignant Mesothelioma
01/2018 - 01/2016
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
12/2017 - 01/2002
2Fever (Fevers)
12/2005 - 05/2005
2Neutropenia
05/2005 - 06/2004
1Thromboembolism
01/2024
1Rhinosinusitis
10/2023

Drug/Important Bio-Agent (IBA)

12ErbB Receptors (EGF Receptor)IBA
02/2024 - 06/2008
11Bleomycin (Blenoxane)FDA LinkGeneric
05/2024 - 01/2009
10Biomarkers (Surrogate Marker)IBA
05/2024 - 07/2011
8Plasminogen Activators (Plasminogen Activator)IBA
02/2023 - 04/2010
8Plasminogen Activator Inhibitor 1IBA
02/2023 - 04/2010
8LigandsIBA
07/2022 - 01/2016
6Immune Checkpoint InhibitorsIBA
02/2024 - 09/2019
6CytokinesIBA
11/2023 - 01/2009
6Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2015
6Tyrosine Kinase InhibitorsIBA
08/2022 - 06/2008
5HMGB1 Protein (HMG1)IBA
01/2023 - 01/2020
5Cisplatin (Platino)FDA LinkGeneric
02/2021 - 05/2005
5Small Interfering RNA (siRNA)IBA
01/2021 - 04/2010
4AnticoagulantsIBA
01/2024 - 03/2019
4Bevacizumab (Avastin)FDA Link
10/2023 - 09/2018
4pembrolizumabIBA
01/2022 - 03/2019
4Carboplatin (JM8)FDA LinkGeneric
11/2021 - 06/2004
4AntibodiesIBA
11/2019 - 12/2005
3osimertinibIBA
02/2023 - 01/2022
3Messenger RNA (mRNA)IBA
01/2023 - 01/2021
3Prednisolone (Predate)FDA LinkGeneric
12/2022 - 01/2018
3SteroidsIBA
12/2022 - 12/2005
3edoxabanIBA
01/2022 - 03/2019
3Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2021 - 06/2011
3Gefitinib (Iressa)FDA Link
10/2021 - 06/2011
3AntigensIBA
04/2021 - 12/2005
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2009
3suplatast tosilateIBA
01/2019 - 01/2009
3SK-216IBA
01/2016 - 11/2013
3Paclitaxel (Taxol)FDA LinkGeneric
10/2011 - 06/2004
2Hydroxyproline (4 Hydroxyproline)IBA
01/2024 - 10/2018
2Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2023 - 01/2021
2AfatinibIBA
10/2023 - 01/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2023 - 01/2022
2Prothrombin (Factor II)IBA
01/2023 - 01/2022
2Immunoglobulin G (IgG)IBA
12/2022 - 04/2022
2EnzymesIBA
02/2021 - 01/2012
2NivolumabIBA
02/2021 - 01/2018
2PlatinumIBA
01/2021 - 01/2019
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2019 - 12/2018
2Mucin-1 (CA 15-3 Antigen)IBA
01/2019 - 12/2017
2ChemokinesIBA
01/2019 - 01/2017
2Pemetrexed (MTA)FDA Link
12/2018 - 09/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2018 - 11/2013
2PowdersIBA
09/2018 - 12/2015
2Docetaxel (Taxotere)FDA Link
09/2018 - 01/2011
2CD13 Antigens (Alanine Aminopeptidase)IBA
01/2018 - 07/2015
2Receptor for Advanced Glycation End ProductsIBA
11/2017 - 01/2017
1Lipocalin-2IBA
05/2024
1Glycoproteins (Glycoprotein)IBA
05/2024
1paquinimodIBA
01/2024
1Hypoxia-Inducible Factor 1IBA
11/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
11/2023

Therapy/Procedure

19Drug Therapy (Chemotherapy)
07/2022 - 01/2011
11Therapeutics
01/2024 - 06/2011
7Radiotherapy
11/2022 - 06/2017
5Chemoradiotherapy
12/2022 - 10/2017
5Traction
02/2021 - 01/2018
2Oral Administration
10/2022 - 06/2017
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2022 - 12/2021
2Nebulizers and Vaporizers (Inhaler)
01/2022 - 09/2018
2Catheters
01/2020 - 01/2018
1Cell Transplantation
11/2023